Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Evaluation of transmission-blocking potential of Pv22 using clinical Plasmodium vivax infections and transgenic Plasmodium berghei

8 Dec 2022

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Malaria Research and Control
Share to Mosquito-borne diseases and control
Share to Parasites and Host Interactions

Source

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Identifiers

PMID: 36503858
DOI: 10.1016/j.vaccine.2022.11.058

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 23 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Evaluation of transmission-blocking potential of Pv22 using clinical Plasmodium vivax infections and transgenic Plasmodium bergheiPMID 36503858Read ↗

Worldwide sequence conservation of transmission-blocking vaccine candidate Pvs230 in Plasmodium vivaxSemantic proximity Read ↗

Rational development of a protective P. vivax vaccine evaluated with transgenic rodent parasite challenge modelsSemantic proximity Read ↗

Potent immunogenicity of DNA vaccines encoding Plasmodium vivax transmission-blocking vaccine candidates Pvs25 and Pvs28—evaluation of homologous and heterologous antigen-delivery prime-boost strategySemantic proximity Read ↗

Evaluation of two Plasmodium vivax sexual-stage antigens as transmission-blocking vaccine candidatesSemantic proximity Read ↗

Evaluation of Plasmodium vivax HAP2 as a transmission-blocking vaccine candidateSemantic proximity Read ↗

Mosquito-based transmission blocking vaccines for interrupting Plasmodium developmentSemantic proximity Read ↗

Identification of three ookinete-specific genes and evaluation of their transmission-blocking potentials in Plasmodium bergheiSemantic proximity Read ↗

Transmission-blocking vaccine of vivax malariaSemantic proximity Read ↗

Genetic diversity and natural selection of transmission-blocking vaccine candidate antigens Pvs25 and Pvs28 in Plasmodium vivax Myanmar isolatesSemantic proximity Read ↗

Implications of Plasmodium vivax Biology for Control, Elimination, and Research.Semantic proximity Read ↗

<i>Plasmodium</i> P25 and P28 Surface Proteins: Potential Transmission-Blocking VaccinesSemantic proximity Read ↗

Sequence Polymorphism in Two Novel Plasmodium vivax Ookinete Surface Proteins, Pvs25 and Pvs28, That Are Malaria Transmission-blocking Vaccine CandidatesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.